Geoffrey M. Nichol's Insider Trades & SAST Disclosures

Geoffrey M. Nichol's most recent trade in Tempest Therapeutics Inc was a trade of 16,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Tempest Therapeutics Inc
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (right to buy)
Tempest Therapeutics Inc
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 8,200 8,200 - - Stock Option (right to buy)
Tempest Therapeutics Inc
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Tempest Therapeutics Inc
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,635 6,635 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades